People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by health ...

Losing weight is one of the most common metformin side effects. Learn more about what the drug is, how it works, and if it’s a diabetes treatment for you.

Addressing metabolic risk factors early with lifestyle change and GLP-1 therapy can reduce cardiovascular risks, says ...

Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...

Vertex has enacted or continued several key launches in 2025. These include its new once-daily triple-combination therapy for ...

Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...

Image from Modular Medical on LinkedIn]Modular Medical (Nasdaq:MODD) announced that it continues to progress toward CE mark ...

A daily pill to help people newly diagnosed with type 1 diabetes, or those at risk of developing it, live without the ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.